Document is current
Any future updates will be listed below
-
Authors
Zuljan, Erika
von der Emde, Benjamin
Piwonski, Iris
Pestana, Ana
Klinghammer, Konrad
Mock, Andreas https://orcid.org/0000-0002-3332-9166
Horak, Peter https://orcid.org/0000-0003-4536-9306
Heining, Christoph
Klauschen, Frederick https://orcid.org/0000-0002-9131-2389
Pretzell, Ina
Boerries, Melanie https://orcid.org/0000-0002-3670-0602
Brandts, Christian H.
Kreutzfeldt, Simon https://orcid.org/0000-0003-3278-4586
Teleanu, Maria-Veronica
Hübschmann, Daniel https://orcid.org/0000-0002-6041-7049
Morris, Luc G. T. https://orcid.org/0000-0002-4417-2280
Heiland, Max https://orcid.org/0000-0002-4987-2913
Keller, Ulrich https://orcid.org/0000-0002-8485-1958
Conrad, Thomas https://orcid.org/0000-0001-5618-6295
Glimm, Hanno https://orcid.org/0000-0003-4104-1135
Fröhling, Stefan https://orcid.org/0000-0001-7907-4595
Ochsenreither, Sebastian https://orcid.org/0000-0001-6024-4312
Keilholz, Ulrich
Blanc, Eric
Beule, Dieter
Rieke, Damian T. https://orcid.org/0000-0003-0027-7977
- License Information
-
More Information
Article History
Received: 25 January 2024
Accepted: 20 May 2025
First Online: 12 June 2025
Competing interests
: C.H. received honoraria, research funding and/or consulting/advisory board from Roche, Novartis, and Boehringer Ingelheim. S.F. reports consultancy fees from Illumina, DTR has received honoraria, research support, and/or travel/accommodation expenses from Bayer, Eli Lilly, Bristol-Myers Squibb, Roche, BeiGene, J&J, and Seagen. The remaining authors report no competing interests.
